Ned Adams
Impact in
- Biotechnology top 10%
- Cancer Research and Treatments
-
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
- Oncology 3
- Cancer Immunotherapy and Biomarkers 2
-
- Glycosylation and Glycoproteins Research 1
- Co-authors
- John Nemunaitis (7 shared papers)Neil Senzer (3 shared papers)Cynthia Bedell (1 shared paper)Michael Nemunaitis (1 shared paper)Anagha P. Phadke (1 shared paper)Yu‐An Zhang (1 shared paper)Yasuo Urata (1 shared paper)Phillip B. Maples (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Vaccines (1 paper)Neurology (1 paper)Cancer Investigation (1 paper)Molecular Therapy (1 paper)
- Partner nations
- United StatesJapanUnited Kingdom
In The Last Decade
Ned Adams
9 papers receiving 320 citations
Peers
Comparison fields: 5 of 49
- Biotechnology 79
- Oncology 132
- Genetics 144
- Molecular Biology 152
- Cancer Research 30
Countries citing papers authored by Ned Adams
This map shows the geographic impact of Ned Adams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ned Adams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ned Adams more than expected).
Fields of papers citing papers by Ned Adams
This network shows the impact of papers produced by Ned Adams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ned Adams. The network helps show where Ned Adams may publish in the future.
Co-authors
The 25 scholars most cited alongside Ned Adams, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 207 | |
| 2 | 2002 | 62 | |
| 3 | 1994 | 24 | |
| 4 | 2017 | 14 | |
| 5 | 2021 | 6 | |
| 6 | 2006 | 5 | |
| 7 | 2014 | 5 | |
| 8 | 2004 | 3 | |
| 9 | Phase I trial of an all-oral combination chemotherapy regimen: topotecan and capecitabine in solid tumor patients. | 2005 | 1 |
About Ned Adams
Ned Adams is a scholar working on Oncology, Molecular Biology, Genetics, Biotechnology and Immunology, having authored 9 papers that have together received 327 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (2 papers), Cancer Research and Treatments (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Venous Thromboembolism Diagnosis and Management (1 paper), Cancer Genomics and Diagnostics (1 paper), Case Reports on Hematomas (1 paper), Heparin-Induced Thrombocytopenia and Thrombosis (1 paper) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Biotechnology (79 citations), Oncology (132 citations), Genetics (144 citations), Molecular Biology (152 citations) and Cancer Research (30 citations). Ned Adams has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include John Nemunaitis, Neil Senzer, Cynthia Bedell, Michael Nemunaitis, Anagha P. Phadke, Yu‐An Zhang, Yasuo Urata, Phillip B. Maples, Beena O. Pappen and Toshiyoshi Fujiwara. Their work appears in journals such as Journal of Clinical Oncology, Vaccines, Neurology, Cancer Investigation and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.